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J. Exp D. The only difference in the effects of these two drugs is that salicylate inhibits RNA synthesis to a much lesser degree than does actinomycin D. Effects from a short exposure to salicylate may he reversible; the same effects wilh actinomycin D cannot be reversed. I n utero exposure of the female fetus may lead to partial or total sterility (depending on the dose and time of exposure) of that fetus and/or abnormal development of the progenv from those mice (F2).
These results suggest that RNA synthesis in early oogenesis is a vital part of later development of the oocytes in adult mouse ovary. Inhibition of RNA may be one of the causes of malformations and sterility.
Speculation
During early stages of development a species of RNA (known as masked messenger RNAj is synthesized by the oocyte nucleus and stored in the cytoplasm. After fertilization this RNA is utilized for the production of proteins necessary for the development of the embryo. If this RNA synthesis is inhibited by some agent (e.g., drugs) malformation or infertility could ensue in the female progeny.
Information on the molecular mechanisms by which some drugs cause malformation in the developing fetus is virtually nonexistent. There is increasing evidence. however, that regulation of early -animal development may be dependent on sequential synthesis of different messenger R N A molecules (mRNA). These m R N A L molecules are stored as stable cytoplasmic ribonucleoprotein particles, which subsequent to fertilization are utilized for the production of specific proteins for a limited time during development (7) . This species of nucleic acid is known as masked messenger R N A . T o date its presence has been documented in amphibian and sea urchin eggs (4). One possible mechanism leading to induction of malformation is by spc cific inhibition of such transcription and/or translation of this r asked messenger R N A during development. It is already known t at an inhibitor of R N A synthesis, such as actinomycin D, caw s developmental defects in amphibian (4) as well as in mammali, 1 eggs (2. 23). It would seem reasonable to believe that a block i R N A synthesis for a short period of time during development t ther directly or indirectly may be responsible for at least some o f t e large number of anomalies induced by drugs in experimental an mals.
The present investigations were designed t o ascertain and compare the effects of acetyl salicylate upon R N A synthesis in mouse oocytes with those of actinomycin D, which is a known inhibitor of DNA-dependent R N A synthesis. Additionally. we administered each of these drugs at a specific time during pregnancy to ascertain the immediate effects on the first generation (FL) and to determine long term effects on the second generation progeny produced by the mating of FI females and normal untreated males.
MATERIALS AND METHODS

OOCYTE COLLECTION AND C U L T U R E
Follicular oocytes were obtained from the ovaries of 8-10-weekold randomly bred I C R / H a strain mice. The ovaries were dissected out and placed on a depression slide containing a mixture of one-half normal saline and one-half Whitten and Bigger's oocyte culture media (22) . They were then teased with a 20-gauge needle and fine forceps to release the oocytes into the media. Subsequent to this procedure, the oocytes with well-defined germinal vesicles were collected into a micropipette and put into a plastic Petri dish containing full strength media under oil. All the oocytes needed for olie experiment were collected and put into culture as quickly as possible to avoid the difference in culture time. Twelve to 15 mice were killed each time to obtain approximately 600 oocytes. The cultures were than incubated at 37' in 5%' CO, in air. Four types of experiments were performed.
In Virro Treatrnent of Ooc,vres with Actinot?lvcin D and Acet1~1 Salicylare. Bloom and Mukherjee (2) have shown that actinomycin D at a concentration of I x 10-I pg/ml or higher prevented maturation of oocytes. However, at a concentration of 1 x lo-' and 1 x @g/ml, oocytes reached metaphase 11, indicating apparent maturity. We have used these three concentrations of actinomycin D ( 1 x lo-', 1 x lo-', and I x pg/rnl). After exposure to actinomycin D for 30 min. oocytes were transferred to media containing [3H]uridine ( 5 pCi/ml sp act: 1,900 mCi m M (26) and left in this media for 4 hr. Similarly, oocytes were treated in acetyl salicylate concentrations ranging from I x 1 0 ' pg/ml to 10 @g/rnl for 30 min, followed by exposure to [3H]uridine (5 pCi/ml) for 4 hr. The control cultures received equal volumes of the solvent, normal saline. The oocytes were then washed thoroughly in saline, fixed on the slide with 1:3 glacial acetic acid and absolute methanol, and air dried. All slides were extracted with trichloroacetic acid (5%) at 4O for 30 min to eliminate the unincorporated isotopic pool. After this, they were coated with Kodak NTB, nuclear track liquid emulsion and exposed in the dark at 4' for 3 weeks before developing. They were stained in buffered Giemsa. All slides were coded and scored blindly by one person. Some slides were digested with RNAase and subsequent autoradiography revealed no radioactivity, indicating the incorporation of [3H]uridine solely in the R N A .
In Vivo Treatment of Oocvtes with Actinomvcin D and Acetyl Salicylate. For this purpose actinomycin D and acetyl salicylate were injected (1.5 m1/20 g body wt) intraperitoneally 1 hr before injection of [3H]uridine (50 ~C i / 2 0 g body wt). The control group received the same volume of solvent plus [3H]uridine. For each treatment, six mice were used. The oocytes were isolated from the ovary and autoradiographs prepared as described above. They were coded and scored blindly by one individual for labeled and nonlabeled oocytes.
In Vitro Fertilization and Development of Treated Oocvres. From our previous experience in treatment of mouse oocytes with actinomycin D and acetyl salicylate and their subsequent development, and from the data presented by Bloom and Mukherjee (2), we arrived at a dosage of these drugs which consistently prevents R N A synthesis without apparent morphologic change in the maturation process of the oocyte. T o find out whether or not these oocytes have full developmental potential, they were utilized for in vitro fertilization and subsequent development to the blastocyst stage. The concentration of the two drugs used in in vitro experiments were actinomycin D, 1 x pg/ml, and acetyl salicylate, 10 pg/ml. The oocytes were exposed to these drugs for I hr and then transferred to fresh drug-free media and allowed to grow to maturity for 10-12 hr. They were then transferred to the fresh culture media with capacitated sperm suspension for in vitro fertilization as described by Mukherjee (12) . The number of oocytes undergoing cleavage was recorded as evidence for fertilization.
lnhibitiot7 o f R N A Synthesis in Fetal Ovarj, and Its Consequences. Since we obtained clear indication that acetyl salicylate does inhibit R N A synthesis in maturing oocytes, we wanted to see the consequences of this inhibition of R N A synthesis in the fetal ovary. In our previous studies we found that R N A synthesis in fetal ovaries takes place as early as 16-18 days of gestation with cytoplasmic storage in the oocyte (14) . The control animals, which were at their 16thbi8th day after the appearance of vaginal plug, received an intraperitoneal injection of 1.5 rnl normal saline divided into three equal injections followed in 1 hr by 5OPCi of [3H]-uridine/mouse. The experimental group received a total of 1.5 ml 10 Fg/ml acetyl salicylate/rnouse in three equal injections on the Itth day and again on the 17th day when peak R N A synthesis occurs. At this time 50 pCi/mouse of [3H]uridine was also administered. Similarly, 1.5 ml actinomycin D at a concentration of 1 x lo-' Fg/ml was injected into each mouse in three equal doses before the injection of [3H]uridine as described for acetyl salicylate. When these progeny were born they were allowed to grow to rnaturity. At this time, the ovaries were taken out, oocytes were isolated, and autoradiographs were prepared. In another group of animals only the drugs were injected into the mother on the 16th-18th day of gestation but no isotope was administered. When these mothers delivered, the progeny were allowed to grow to maturity. At 6-8 weeks of age the female progeny were mated with males of proven fertility to see whether normal pregnancy resulted. These data were compared with that of the control progeny whose mothers received equal volumes of the drug solvents on the same days as the drug was introduced to the experimental group.
RESULTS
The normal process of maturation of oocytes in vitro has been published elsewhere (1 3). Approximately 9 of the oocytes reached second metaphase of meiosis at 16-17 hr after initiation of the cultures. In the labeling experiments with [3H]uridine it has been observed that appreciable isotope incorporation took place between 2 6 hr. Therefore. in all experiments a 4-hr pulse was used. incorporation of [3H]uridine was indeed ~n t o the R N A of the oocytes. This was confirmed because ( I ) the isotope was not (Fig. 1) . Table I (Tables I and 2 ).
The most important biologic assay for the effects of inhibition of R N A synthesis came from our observations on in virro and in vivo fertilization. The result3 of in vitro fertilization using the treated oocytes and capacitated sperm are provided in Table 3 . It is clear from these data that actinomycin D, at a concentration which allows apparent progression of the oocytes t o the second metaphase, does affect the process of fertilization, as well as normal c!eavage and development of the embryo. Also, acetyl salicylate, like actinomycin D, prevented normal fertilization and developmental processes in the mouse. The R N A synthesis in the fetal ovary during 1 6 t h 1 8 t h days of gestation was inhibited when actinomycin D a n d / o r acetyl salicy- (Table 4) . Subsequently, when these progeny were tested for fertility, they were found to have lower capacity to reproduce than the controls. Although some morphologically normal progeny were born to the dams who received the drug, they were nonetheless definitely affected by the drugs as judged by their reproductive capability. It is quite evident from Table 5 that in utero-treated females had less ability to reproduce and gave birth to more abnormal progeny when compared with the controls. Various abnormalities in the first generation included extreme reduction in size of the fetuses in the treated group compared with nontreated controls (Figs. 2 and 3) . However, a majority of the female progeny that received the drugs in utero had extreme reabsorption of the embryos (Fig. 4) or they were completely sterile (depending on the dose of the drug).
potential of mouse oocytes, presented in this report, have not been shown previously. The demonstration in the present investigation that acetyl salicylate, like actinomycin D, inhibits R N A synthesis in oocytes during development is important from the standpoint of fetal malformations in other species, perhaps including man, because with a few exceptions every prenatally ingested medication crosses the placenta ( I I) and in the United States mothers take an average of 4-5 medications during pregnancy (15, 17) .
The teratogenic effects of salicylate in the mouse (9, 19) and in the rabbit (5, 19) are well documented. However, a review of the literature on the effects of salicylate on early development in mammals shows that very few studies have been performed concerning the effects on the preimplantation stages of embryos (6) . Young et al.. in 1972 (25) , have shown toxic effects of sodium salicylate on preimplantation mouse embryos in a preliminary study. In Young's study only morphologic criteria of survival of embryos were studied. The present investigations point to one of the mechanisms by which malformations and/or lethal effects of some drugs may be exerted during early development, e.g., by inhibition of R N A synthesis in the oocyte. Aspirin and other salicylates have been recognized as teratogens in rats since the first report by Warkany and Takaes (21) . Recently, Janakidevi and 4 . A normal placenta compared to the reabsorbed fetus recovered essential and integral part of the process of development and from a mouse which was exposed to salicylate h urero during 15-18 days of differentiation. Additionally, these results point to the possibility gestation.
that the inhibition of nucleic acid synthesis may be one of the reasons for the teratogenic effect and the reduction of fertility in the female mouse when exposed to acetyl salicylate in utero. The reduction in fertility or complete sterility (depending on the dose) because of salicylate treatment in utero of the female fetus may be taken as indirect evidence of the inhibition of masked messenger R N A synthesis in the developing oocytes. It has been shown by Rudkin and Griech (18) and Borum (3) that the oocytes contained in the adult mouse ovary persist from fetal life and that the last round of DNA synthesis takes place in these oocytes during the 12th15th day of gestation. Our autoradiographic data obtained by injecting [3H]uridine into pregnant mice on the the 16th 18th day of gestation and recovering oocytes from adult progeny whose cytoplasm contained labeled R N A suggest that perhaps this is the time during which the fetal overy synthesizes masked messenger RNA, which is then stored in oocyte cytoplasm for future use after fertilization. This view has been further supported by the fact that the developmental potential of the oocytes of the progeny that received salicylate in utero during the 1 6 t h 1 8 t h day of gestation is indeed reduced ( Table 5 ). This effect of salicylate had been reported by Wright (24) who studied the toxicity of various analgesic and antipyrectic drugs for five generations in the mouse.
In conclusion, the present investigations suggest a possible mechanism for the adverse effects of salicylate in concentrations which fall within the therapeutic range in man, on the normal maturation and development of mouse oocytes. Extrapolation of these findings to humans must be considered with caution, in view of the difference in the process of oocyte maturation in human as compared with the mouse. However, the results of this study may be used to illustrate that drugs may affect progeny (at least in the mouse) adversely in one of three ways: ( I ) by directly affecting the offspring in the early developmental processes such as organogenesis; (2) by antagonizing the R N A synthesis of their own oocytes during maturation in the ovary, and (3) by preventing R N A synthesis in the oocytes and/or normal maturation of the oocytes in their female offspring, thereby imposing sterility or the production of malformations in the subsequent generation.
S U M M A R Y
The effects of acetyl salicylate and actinomycin D on R N A synthesis in the mouse oocyte were compared by in vitro and in vivo experiments. After exposure to the drugs the effects on R N A synthesis were measured by incorporation of [3H]uridine and autoradiography. The results indicate that acetyl salicylate inhibits R N A synthesis in the treated oocytes in a manner similar to actinomycin D. The effects from a short exposure to salicylate may be reversible, whereas, the same effects with actinomycin D cannot be reversed. I n zrtero exposure of the female fetus may lead to partial or total sterility (depending on the dose and time of exposure) of that fetus and/or abnormal development of subsequent progeny.
These results suggests that R N A synthesis in early oogenesis plays a vital role in the later development of the oocytes in adult mouse ovary. lnhibition of this early R N A synthesis may be one of the causes of subsequent malformations and sterility in future offspring.
